FDG PET of the brain to screen for neurodegenerative disease in older liver transplant candidates [0.03%]
老年肝移植受者脑部 FDG-PET 筛查神经退行性疾病的价值
Natalie Jones,Trent M Schwartz,Steven Bishay et al.
Natalie Jones et al.
Ischemic Heart Disease in Liver Transplant Candidates With High Bleeding Risk: Any Way Out? [0.03%]
高出血风险肝移植受者的缺血性心脏病：何去何从？
Chiara Del Carlo,Lorenza Santoni,Iacopo Fabiani et al.
Chiara Del Carlo et al.
Coronary artery disease in candidates for liver transplantation is a real challenge because of the need to balance the risks of bleeding and thrombosis. Antiplatelet therapy, essential to prevent thrombotic events, may increase the risk of ...
Home-based LIver FrailTy Intervention (LIFT) in Transplant Candidates: A Feasibility Study [0.03%]
肝移植候选人的家庭式肝脏脆弱性干预(LIFT): 一项可行性研究
Avesh J Thuluvath,Praneet Polineni,Sheila Morrissey et al.
Avesh J Thuluvath et al.
Background: Frailty is prevalent in end-stage liver disease and predicts higher waitlist and posttransplant mortality. Despite association of frailty with poor clinical outcomes, evidence-based interventions to reverse fr...
Listing for blood type A2 donors is highly variable and impacts waitlist outcomes among blood type O liver transplantation candidates in the United States [0.03%]
在美国，血型O的肝移植候选人中，血型A2供体的列表高度变化并影响等待名单的结果
Toshihiro Nakayama,Yuki Imaoka,Carlos O Esquivel et al.
Toshihiro Nakayama et al.
Blood type O liver transplantation (LT) candidates in the United States face the highest waitlist mortality due to the broader compatibility of type O grafts. Although blood-type compatible transplant is a gold standard, type O candidates m...
Processing mobility data through artificial intelligence can identify patterns of physical activity in liver transplant candidates [0.03%]
通过人工智能处理移动数据可以识别肝脏移植候选人的身体活动模式
Rachel Orbuch,Pamela M Bloomer,Ervic Sejdic et al.
Rachel Orbuch et al.
Diastolic dysfunction: Prevalence and outcome in liver transplantation candidates [0.03%]
舒张功能障碍：肝移植候补者的患病率及预后
Francis Voet,Maxim Khalenkow,Michel De Pauw et al.
Francis Voet et al.
Introduction and objectives: Cirrhotic cardiomyopathy (CCM) is a cardiac complication of cirrhosis primarily presenting as diastolic dysfunction (DD). The original diagnostic criteria from 2005 were updated in 2019. This ...
Statin Therapy is Associated With Lower Risk of Mortality Among Liver Transplant Candidates With Metabolic Dysfunction-associated Steatohepatitis [0.03%]
他汀治疗与代谢功能异常相关肝炎终末期肝病等待移植患者预后改善有关
Katherine M Cooper,Ami K Patel,Christopher A Zammitti et al.
Katherine M Cooper et al.
Background: Statin therapy is historically underutilized in patients with chronic liver disease. There is increasing evidence to support the use of statins in patients with cirrhosis, though data in decompensated patients...
Splanchnic Venous Thrombectomy Using the VenaCore Thrombectomy Catheter in a Liver Transplantation Candidate [0.03%]
肝移植候选人的腹腔静脉血栓切除术使用VenaCore血栓切除导管
David S Shin,Matthew Abad-Santos,Eric J Monroe et al.
David S Shin et al.
Echocardiographic Screening of Liver Transplant Candidates-Prevalence of Features of Portopulmonary Hypertension [0.03%]
肝移植供体的超声心动图筛选-门脉肺高血压特征的流行率
Olga Dzikowska-Diduch,Tomasz Cader,Krzysztof Jankowski et al.
Olga Dzikowska-Diduch et al.
Background: The prevalence of portopulmonary hypertension (PoPH) is relatively low; however, its presence significantly worsens patients' prognosis. When diagnosed, PoPH can be effectively treated, and specific therapies can lead to a subst...
耗时 0.13356 秒，为您在
48229835
条记录里面共找到 300 篇文章 [XML]